Please do not leave this page until complete. This can take a few moments.
Worcester Polytechnic Institute researcher and biomedical engineering professor Karen Troy was awarded $463,645 by the National Institutes of Health to study the causes of foot injuries among female runners, according to a Tuesday press release from
TransCode Therapeutics, Inc., an RNA oncology company, announced on July 13 it would close its initial public offering of nearly 7.2 million shares at $4 per share.
Bolton-based Intrinsic Imaging, a provider of medical imaging lab services, has been acquired by WCG of Princeton, N.J.
The Cryo-EM Core facility at UMass Medical School received $2.8 million from the Massachusetts Life Sciences Center on Thursday to purchase a cryo-electron microscope to support the team’s structural biology research.
Worcester Polytechnic Institute researcher Amity Manning has been awarded a $799,995 grant from the American Cancer Society to determine the role a critical tumor-suppressor protein plays in chromosome errors arising during cell division in cancer
UMass Medical School in Worcester is participating in a study of antibodies treatments for COVID-19.
Natick-based Aleta Biotherapeutics has announced a partnership with Cancer Research UK to study Aleta’s cancer therapy candidate.
Leukocare, which has its U.S. operations based in Milford, announced on Wednesday it has raised $17.5 million from New York investment firm Petrichor Healthcare Capital Management.
Worcester biotech firm Mustang Bio has received $300,000 in tax incentives from the Massachusetts Life Sciences Center after committing to new hiring this year.
Akoya Biosciences, a Marlborough firm analyzing tissues for therapy research, announced Wednesday it will be joining the broad-market Russell 3000 Index.
Framingham life science consulting firm Alira Health announced Tuesday it has acquired CROS NT, a contract research organization headquartered in Italy with offices across Europe and the United States.
Over the next year and a half, Commonwealth Fusion Systems is building a $300-million, 47-acre headquarters in Devens, in its $1-billion, long-term effort to make fusion the default energy source on Earth
Akoya Biosciences, a Marlborough firm analyzing tissues for therapy research, announced increases in revenue and profits in the first quarter, along with plans to continue hiring new employees.
A chemistry professor at the College of the Holy Cross in Worcester has been awarded more than $400,000 from the National Science Foundation to study how molecules mix with each other.
Marlborough drugmaker Phio Pharmaceuticals has ended the first quarter with $32.7 million in cash on hand, amid climbing losses due to increased research and development of its cancer-therapy technology.
UMass Memorial Health of Worcester announced on Tuesday it helped create a new TeamBirth partnership with Wellesley insurer Harvard Pilgrim Health Care and Boston health center Ariadne Labs to launch a new initiative at the UMass hospitals in